First-of-its-Kind study to track CF drugs in expecting and nursing moms
NCT ID NCT04940533
Summary
This study aims to measure how pregnancy and breastfeeding affect the levels of modern cystic fibrosis (CF) medications in a mother's body. Researchers will track 30 women with CF who are taking these medications while pregnant and after giving birth. The goal is to gather safety information to help doctors better counsel future mothers with CF about medication use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.